These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 36504617)

  • 1. Anti-virulence therapeutic strategies against bacterial infections: recent advances.
    Dehbanipour R; Ghalavand Z
    Germs; 2022 Jun; 12(2):262-275. PubMed ID: 36504617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathoblockers or antivirulence drugs as a new option for the treatment of bacterial infections.
    Calvert MB; Jumde VR; Titz A
    Beilstein J Org Chem; 2018; 14():2607-2617. PubMed ID: 30410623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The arsenal of pathogens and antivirulence therapeutic strategies for disarming them.
    Brannon JR; Hadjifrangiskou M
    Drug Des Devel Ther; 2016; 10():1795-806. PubMed ID: 27313446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antivirulence Strategies for the Treatment of
    Ford CA; Hurford IM; Cassat JE
    Front Microbiol; 2020; 11():632706. PubMed ID: 33519793
    [No Abstract]   [Full Text] [Related]  

  • 5. Green synthesis of silver nanoparticles using Carum copticum: Assessment of its quorum sensing and biofilm inhibitory potential against gram negative bacterial pathogens.
    Qais FA; Shafiq A; Ahmad I; Husain FM; Khan RA; Hassan I
    Microb Pathog; 2020 Jul; 144():104172. PubMed ID: 32224208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global priority pathogens: virulence, antimicrobial resistance and prospective treatment options.
    M Campos JC; Antunes LC; Ferreira RB
    Future Microbiol; 2020 May; 15():649-677. PubMed ID: 32495702
    [No Abstract]   [Full Text] [Related]  

  • 7. Antipathogenic Compounds That Are Effective at Very Low Concentrations and Have Both Antibiofilm and Antivirulence Effects against Pseudomonas aeruginosa.
    Hwang HJ; Choi H; Hong S; Moon HR; Lee JH
    Microbiol Spectr; 2021 Oct; 9(2):e0024921. PubMed ID: 34494853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antivirulence as a new antibacterial approach for chemotherapy.
    Escaich S
    Curr Opin Chem Biol; 2008 Aug; 12(4):400-8. PubMed ID: 18639647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial genome engineering and synthetic biology: combating pathogens.
    Krishnamurthy M; Moore RT; Rajamani S; Panchal RG
    BMC Microbiol; 2016 Nov; 16(1):258. PubMed ID: 27814687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Musa acuminata and its bioactive metabolite 5-Hydroxymethylfurfural mitigates quorum sensing (las and rhl) mediated biofilm and virulence production of nosocomial pathogen Pseudomonas aeruginosa in vitro.
    Vijayakumar K; Ramanathan T
    J Ethnopharmacol; 2020 Jan; 246():112242. PubMed ID: 31533077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting Type VI Secretion System Activity with a Biomimetic Peptide Designed To Target the Baseplate Wedge Complex.
    Cherrak Y; Filella-Merce I; Schmidt V; Byrne D; Sgoluppi V; Chaiaheloudjou R; Betzi S; Morelli X; Nilges M; Pellarin R; Durand E
    mBio; 2021 Aug; 12(4):e0134821. PubMed ID: 34372705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel agents to inhibit microbial virulence and pathogenicity.
    Escaich S
    Expert Opin Ther Pat; 2010 Oct; 20(10):1401-18. PubMed ID: 20718591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of quorum sensing, biofilm formation, and iron acquisition as key virulence mechanisms in Acinetobacter baumannii and the corresponding anti-virulence strategies.
    Law SKK; Tan HS
    Microbiol Res; 2022 Jul; 260():127032. PubMed ID: 35483311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of FDA-Approved Drugs as Antivirulence Agents Targeting the
    D'Angelo F; Baldelli V; Halliday N; Pantalone P; Polticelli F; Fiscarelli E; Williams P; Visca P; Leoni L; Rampioni G
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30201815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty Acids as Antibiofilm and Antivirulence Agents.
    Kumar P; Lee JH; Beyenal H; Lee J
    Trends Microbiol; 2020 Sep; 28(9):753-768. PubMed ID: 32359781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plant Natural Products Targeting Bacterial Virulence Factors.
    Silva LN; Zimmer KR; Macedo AJ; Trentin DS
    Chem Rev; 2016 Aug; 116(16):9162-236. PubMed ID: 27437994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antivirulence properties and related mechanisms of spice essential oils: A comprehensive review.
    Zhang D; Gan RY; Zhang JR; Farha AK; Li HB; Zhu F; Wang XH; Corke H
    Compr Rev Food Sci Food Saf; 2020 May; 19(3):1018-1055. PubMed ID: 33331691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. African Plant-Based Natural Products with Antivirulence Activities to the Rescue of Antibiotics.
    Mahavy CE; Duez P; ElJaziri M; Rasamiravaka T
    Antibiotics (Basel); 2020 Nov; 9(11):. PubMed ID: 33228261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in Anti-virulence Therapeutic Strategies With a Focus on Dismantling Bacterial Membrane Microdomains, Toxin Neutralization, Quorum-Sensing Interference and Biofilm Inhibition.
    Fleitas Martínez O; Cardoso MH; Ribeiro SM; Franco OL
    Front Cell Infect Microbiol; 2019; 9():74. PubMed ID: 31001485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quorum-Sensing Systems as Targets for Antivirulence Therapy.
    Defoirdt T
    Trends Microbiol; 2018 Apr; 26(4):313-328. PubMed ID: 29132819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.